NC
PRTA icon

nVerses Capital’s Prothena Corp PRTA Stock Holding History

nVerses Capital’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$130K Buy
+13,246
New +$131K 0.2% 228

Other funds holding PRTA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

nVerses Capital's PRTA Position: Q2 2026 in Review

nVerses Capital opened a new position in Prothena Corp (PRTA) in Q2 2026: 13,246 shares worth $130K. The stake represents 0.2% of the portfolio and ranks #228 among its holdings.

130 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • nVerses Capital held 13,246 shares of Prothena Corp worth $130K as of Q2 2026.
  • Prothena Corp was a new nVerses Capital position in Q2 2026.
  • Prothena Corp made up 0.2% of nVerses Capital's portfolio in Q2 2026, its #228 holding.
  • 130 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.